The LancetVolume 395, Issue 10224, 22–28 February 2020, Pages e35-e36CorrespondenceReducing mortality from 2019-nCoV: host-directed therapies should be an optionAuthor links open overlay panelAlimuddin Zumla a b, David S Hui c, Esam I Azhar d, Ziad A Memish e f, Markus Maeurer g hShow moreShareCitehttps://doi.org/10.1016/S0140-6736(20)30305-6Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier Ltd. All rights reserved.